Case Study
OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Macromolecules can potentially be converted from injectable to oral drug delivery.
View Now
Article
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
View Now
Presentation
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.
View Now
Poster
OptiShell® Technology Capsule Innovations
New shell and hot-filling that are highly viscous or semi-solid at room temperature
View Now
